Quantum Biopharma Class B Subordinate Voting Shares
QNTM
19 hedge funds and large institutions have $369K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.
171% more call options, than puts
Call options by funds: $211K | Put options by funds: $78K
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0.03% less ownership
Funds ownership: 0.05% → 0.02% (-0.03%)
5% less funds holding
Funds holding: 20 → 19 (-1)
73% less capital invested
Capital invested by funds: $1.38M → $369K (-$1.01M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$159K |
| 2 |
Renaissance Technologies
New York
|
+$18K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
+$16.1K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$14.2K |
| 5 |
Jane Street
New York
|
+$12.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$1.01M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$80.4K |
| 3 |
Millennium Management
New York
|
-$38K |
| 4 |
VF
Virtu Financial
New York
|
-$20.7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$5.93K |
QNTM Hedge Fund Activity: Q1 2022 in Review
19 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q1 2022, worth a combined $369K — down 73% from $1.38M a quarter earlier.
Fund positioning in QNTM was balanced in Q1 2022: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 3 trimmed.
The largest buyer was AdvisorShares Investments, opening a new position worth an estimated $159K. The largest seller was Mirae Asset Global Investments, exiting entirely with an estimated $1.01M sold.
- 19 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q1 2022, down from 20 in Q4 2021.
- Funds reported $369K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q1 2022, down 73% quarter-over-quarter.
- 4 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q1 2022 and 4 closed out, a net change of 0 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q1 2022 was AdvisorShares Investments, an estimated $159K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q1 2022 was Mirae Asset Global Investments, an estimated $1.01M sold.
Based on aggregated 13F filings for Q1 2022.